Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GMIP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | CT45A9 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
mRNA | EEF1AKMT1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
mRNA | TAS2R1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | SHISA5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
mRNA | SPATA2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | MCOLN2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | PPP3CB | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | DHX15 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |